Spots Global Cancer Trial Database for hematologic cancer
Every month we try and update this database with for hematologic cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Photobiomodulation for Oral Mucositis and Functional Impairments During Hematopoietic Stem Cell Transplantation | NCT06260111 | Hematologic Can... | Photobiomodulat... Usual care | 18 Years - 70 Years | Universidad del Desarrollo | |
| Improving Comprehensive Care of Cancer Patients | NCT05323409 | Breast Cancer Gastrointestina... Hematologic Can... | OPTIMISE | 18 Years - | Baylor College of Medicine | |
| Study to Evaluate Adverse Events, Change in Disease Activity, and How Oral ABBV-101 Moves Through the Body in Adult Participants With B-Cell Malignancies | NCT05753501 | Hematologic Can... | ABBV-101 | 18 Years - | AbbVie | |
| SURGE: Supporting UnderRepresented Minorities in Genomics-based Cancer Trial Enrollment (Intervention) | NCT05375643 | Gastrointestina... Hematologic Can... Thoracic Cancer | SURGE | 18 Years - | Dana-Farber Cancer Institute | |
| Hypnosis: a Path to Appeasement | NCT05942885 | Hematologic Can... | anxiety questio... | 18 Years - | Hospices Civils de Lyon | |
| Symptom Management for YA Cancer Survivors | NCT04035447 | Cancer Young Adult Pain Psychological D... Fatigue Breast Cancer Melanoma Hematologic Can... Germ Cell Tumor Endocrine Cance... | Behavioral Symp... | 18 Years - 39 Years | Duke University | |
| The Point of View of Hematological Cancer Patients and Their Loved Ones Regarding Spirituality | NCT04412135 | Hematologic Can... | spirituality | 18 Years - | University Hospital, Limoges | |
| QUALITOP - Monitoring Multidimensional Aspects of QUAlity of Life After Cancer ImmunoTherapy, an Open Smart Digital Platform for Personalized Prevention and Patient Management | NCT05626764 | Solid Tumor Hematologic Can... | QoL & irAEs det... QoL & irAEs det... | 18 Years - | Hospices Civils de Lyon | |
| Effect on Patient Quality of Life of Taking Into Account the Spiritual Dimension in Nurse's Care for Haematologic Cancers. | NCT03698656 | Acute Leukemia Lymphoma | Spiritual Inter... | 18 Years - | University Hospital, Toulouse | |
| Coverage and Cost-of-Care (CC) Links- Financial Navigation Program | NCT05465577 | Financial Stres... Hematologic Can... Survivorship | CC Links | 18 Years - 100 Years | University of Kentucky | |
| The Point of View of Hematological Cancer Patients and Their Loved Ones Regarding Spirituality | NCT04412135 | Hematologic Can... | spirituality | 18 Years - | University Hospital, Limoges | |
| Discontinuation Study | NCT05866757 | Multiple Myelom... Cancer Hematologic Can... | Discontinuation... | 18 Years - | University College Cork | |
| Study to Evaluate Adverse Events, Change in Disease Activity, and How Oral ABBV-101 Moves Through the Body in Adult Participants With B-Cell Malignancies | NCT05753501 | Hematologic Can... | ABBV-101 | 18 Years - | AbbVie | |
| Coverage and Cost-of-Care (CC) Links- Financial Navigation Program | NCT05465577 | Financial Stres... Hematologic Can... Survivorship | CC Links | 18 Years - 100 Years | University of Kentucky | |
| Safety Study of IPI-504 in Patients With Relapsed and Relapsed Refractory Multiple Myeloma | NCT00113204 | Multiple Myelom... | IPI-504 | 18 Years - | Infinity Pharmaceuticals, Inc. | |
| Safety Study of IPI-504 in Patients With Relapsed and Relapsed Refractory Multiple Myeloma | NCT00113204 | Multiple Myelom... | IPI-504 | 18 Years - | Infinity Pharmaceuticals, Inc. | |
| Research-Action in Hematology From Hospitalization to Home | NCT06053918 | Hematologic Can... | additional foll... | 18 Years - | University Hospital, Caen | |
| Antiminor Histocompatibility Complex (MiHA) T Cells for Patients With Relapsed Hematologic Malignancies Following Matched HSCT (Guided Lymphocyte Immunopeptide Derived Expansion) | NCT03091933 | Hematologic Can... Relapse Leukemi... Relapsed Adult ... Relapsed Adult ... Relapsed CLL Relapsed Non Ho... Relapsed Hodgki... Relapsed Myelod... Relapsed Multip... | GLIDE | 18 Years - 65 Years | Ciusss de L'Est de l'Île de Montréal | |
| Photobiomodulation for Oral Mucositis and Functional Impairments During Hematopoietic Stem Cell Transplantation | NCT06260111 | Hematologic Can... | Photobiomodulat... Usual care | 18 Years - 70 Years | Universidad del Desarrollo | |
| CAncer, NUtrition and Taste - Validation of the CANUT-QVA Questionnaire on Eating Habits in Cancer Patients | NCT04235153 | Hematologic Can... Undernutrition Chemotherapy Ef... Taste Disorders Chemotherapy-In... Olfactory Disor... | Evaluation of t... | 18 Years - | Hospices Civils de Lyon | |
| Antiminor Histocompatibility Complex (MiHA) T Cells for Patients With Relapsed Hematologic Malignancies Following Matched HSCT (Guided Lymphocyte Immunopeptide Derived Expansion) | NCT03091933 | Hematologic Can... Relapse Leukemi... Relapsed Adult ... Relapsed Adult ... Relapsed CLL Relapsed Non Ho... Relapsed Hodgki... Relapsed Myelod... Relapsed Multip... | GLIDE | 18 Years - 65 Years | Ciusss de L'Est de l'Île de Montréal | |
| Intervention for Fatigue in HCT Recipients | NCT05715047 | Hematologic Can... Hematologic Mal... | CBT for Fatigue Usual Care | 18 Years - | Massachusetts General Hospital | |
| Early Detection of Complications During Immunotherapy for Haematological Malignancy | NCT06377059 | Hematologic Can... CRS - Cytokine ... | WARD | 18 Years - | Rigshospitalet, Denmark | |
| Study of Benralizumab in People With Skin Side Effects Caused by Cancer Therapies | NCT04552288 | Solid Tumor Solid Carcinoma Solid Tumor, Ad... Hematologic Mal... | Benralizumab | 18 Years - 85 Years | Memorial Sloan Kettering Cancer Center | |
| Discontinuation Study | NCT05866757 | Multiple Myelom... Cancer Hematologic Can... | Discontinuation... | 18 Years - | University College Cork | |
| Avera Cancer Sequencing and Analytics Protocol (ASAP) | NCT05142033 | Cancer Cancer Diagnosi... Early Detection... Breast Cancer Lung Cancer Colon Cancer GI Cancer Gynecologic Can... Ovarian Cancer Endometrial Can... CNS Cancer Hematologic Can... | 18 Years - | Avera McKennan Hospital & University Health Center | ||
| Muscle Stimulation for Physical Function During Stem Cell Transplant | NCT04364256 | Autologous Hema... | RS-4i Plus Sequ... | 18 Years - | VA Office of Research and Development | |
| Genomic Profiling in Cancer Patients | NCT01775072 | Solid Tumors Hematologic Can... | molecular profi... Clinical Germli... | - | Memorial Sloan Kettering Cancer Center | |
| Cancer Rehab Program for Allogenic Bone and Marrow Transplant Patients - CaRE-4-alloBMT | NCT04966156 | Allogeneic Dise... Hematologic Can... Cancer Rehabili... | CaRE-4-alloBMT ... | 18 Years - | University Health Network, Toronto | |
| TORQUETENOVIRUS IN CAR-T THERAPY: PREDICTION OF THE CRS | NCT04822974 | Hematologic Can... | blood collectio... | 18 Years - | Institut Paoli-Calmettes | |
| Physical Therapy in Patients Undergoing Allo-HSCT With cGVHD | NCT06279585 | Graft-versus-ho... Graft Versus Ho... Stem Cell Trans... Hematological M... Hematologic Can... | Physical therap... | 18 Years - | University of Seville | |
| SURGE: Supporting UnderRepresented Minorities in Genomics-based Cancer Trial Enrollment (Intervention) | NCT05375643 | Gastrointestina... Hematologic Can... Thoracic Cancer | SURGE | 18 Years - | Dana-Farber Cancer Institute | |
| Safety Study of IPI-504 in Patients With Relapsed and Relapsed Refractory Multiple Myeloma | NCT00113204 | Multiple Myelom... | IPI-504 | 18 Years - | Infinity Pharmaceuticals, Inc. | |
| CEFtolozane-Tazobactam for the Empiric Anti-bacterial Treatment of Neutropenic Fever in Hematology Patients | NCT05061654 | Neutropenia, Fe... Hematologic Can... | Ceftolozane-taz... | 18 Years - | Hamad Medical Corporation | |
| Improving Patient Experience: BMBA | NCT05690230 | Bone Marrow Can... Leukemia Lymphoma Multiple Myelom... Hematologic Can... | Virtual reality Environmental c... | 18 Years - | Thomas Jefferson University | |
| Aza With or Without ATRA in Newly Diagnosed Unfit AML or Intermediate,High or Very High Risk MDS | NCT05175508 | AML MDS Old Age; Debili... Hematologic Can... | Azacitidine all trans retin... | 18 Years - 80 Years | The First Affiliated Hospital of Soochow University | |
| Evaluate the Safety and Efficacy for Oral Mucositis Prevention of MIT-001 in Auto HSCT | NCT05493800 | Oral Mucositis Lymphoma Multiple Myelom... Hematologic Can... | MIT-001 normal saline | 19 Years - 70 Years | MitoImmune Therapeutics | |
| Anti-GPRC5D CAR-T Cells (CT071) in Participants With RRMM or RRpPCL | NCT06333509 | Multiple Myelom... Primary Plasma ... | CT071 | 18 Years - | CARsgen Therapeutics Co., Ltd. |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
